346 related articles for article (PubMed ID: 27692322)
1. TLR-2 and TLR-4 transcriptions in unstimulated blood from dogs with leishmaniosis due to Leishmania infantum at the time of diagnosis and during follow-up treatment.
Montserrat-Sangrà S; Alborch L; Ordeix L; Solano-Gallego L
Vet Parasitol; 2016 Sep; 228():172-179. PubMed ID: 27692322
[TBL] [Abstract][Full Text] [Related]
2. Early reduction of Leishmania infantum-specific antibodies and blood parasitemia during treatment in dogs with moderate or severe disease.
Solano-Gallego L; Di Filippo L; Ordeix L; Planellas M; Roura X; Altet L; Martínez-Orellana P; Montserrat S
Parasit Vectors; 2016 May; 9(1):235. PubMed ID: 27160317
[TBL] [Abstract][Full Text] [Related]
3. Leishmania infantum-specific IFN-γ production in stimulated blood from dogs with clinical leishmaniosis at diagnosis and during treatment.
Martínez-Orellana P; Marí-Martorell D; Montserrat-Sangrà S; Ordeix L; Baneth G; Solano-Gallego L
Vet Parasitol; 2017 Dec; 248():39-47. PubMed ID: 29173539
[TBL] [Abstract][Full Text] [Related]
4. Long-term follow-up of dogs with leishmaniosis treated with meglumine antimoniate plus allopurinol versus miltefosine plus allopurinol.
Manna L; Corso R; Galiero G; Cerrone A; Muzj P; Gravino AE
Parasit Vectors; 2015 May; 8():289. PubMed ID: 26017164
[TBL] [Abstract][Full Text] [Related]
5. Transcription of Toll-Like Receptors 2, 3, 4 and 9, FoxP3 and Th17 Cytokines in a Susceptible Experimental Model of Canine Leishmania infantum Infection.
Hosein S; Rodríguez-Cortés A; Blake DP; Allenspach K; Alberola J; Solano-Gallego L
PLoS One; 2015; 10(10):e0140325. PubMed ID: 26465878
[TBL] [Abstract][Full Text] [Related]
6. Leishmania infantum-specific IgG, IgG1 and IgG2 antibody responses in healthy and ill dogs from endemic areas. Evolution in the course of infection and after treatment.
Solano-Gallego L; Riera C; Roura X; Iniesta L; Gallego M; Valladares JE; Fisa R; Castillejo S; Alberola J; Ferrer L; Arboix M; Portús M
Vet Parasitol; 2001 Apr; 96(4):265-76. PubMed ID: 11267753
[TBL] [Abstract][Full Text] [Related]
7. Changes in the concentration of anti-Leishmania antibodies in saliva of dogs with clinical leishmaniosis after short-term treatment.
Cantos-Barreda A; Escribano D; Cerón JJ; Tecles F; Bernal LJ; Martínez-Subiela S
Vet Parasitol; 2018 Apr; 254():135-141. PubMed ID: 29656998
[TBL] [Abstract][Full Text] [Related]
8. Changes in serum anti-Leishmania antibody concentrations measured by time-resolved immunofluorometric assays in dogs with leishmaniosis after treatment.
Cantos-Barreda A; Escribano D; Martínez-Subiela S; Pardo-Marín L; Segarra S; Cerón JJ
Vet Immunol Immunopathol; 2018 Apr; 198():65-69. PubMed ID: 29571520
[TBL] [Abstract][Full Text] [Related]
9. Toll-like receptors 2, 4 and 7, interferon-gamma and interleukin 10, and programmed death ligand 1 transcripts in skin from dogs of different clinical stages of leishmaniosis.
Ordeix L; Montserrat-Sangrà S; Martínez-Orellana P; Baxarias M; Solano-Gallego L
Parasit Vectors; 2019 Dec; 12(1):575. PubMed ID: 31806038
[TBL] [Abstract][Full Text] [Related]
10. Potential of Artesunate in the treatment of visceral leishmaniasis in dogs naturally infected by Leishmania infantum: Efficacy evidence from a randomized field trial.
Medkour H; Bitam I; Laidoudi Y; Lafri I; Lounas A; Hamidat HK; Mekroud A; Varloud M; Davoust B; Mediannikov O
PLoS Negl Trop Dis; 2020 Dec; 14(12):e0008947. PubMed ID: 33338041
[TBL] [Abstract][Full Text] [Related]
11. The inflammatory cytokine effect of Pam3CSK4 TLR2 agonist alone or in combination with Leishmania infantum antigen on ex-vivo whole blood from sick and resistant dogs.
Martínez-Orellana P; Quirola-Amores P; Montserrat-Sangrà S; Ordeix L; Llull J; Álvarez-Fernández A; Solano-Gallego L
Parasit Vectors; 2017 Mar; 10(1):123. PubMed ID: 28288677
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of the sesquiterpene (-)-α-bisabolol in dogs with naturally acquired canine leishmaniosis: an exploratory clinical trial.
Corpas-López V; Merino-Espinosa G; Acedo-Sánchez C; Díaz-Sáez V; Navarro-Moll MC; Morillas-Márquez F; Martín-Sánchez J
Vet Res Commun; 2018 Jun; 42(2):121-130. PubMed ID: 29453596
[TBL] [Abstract][Full Text] [Related]
13. Thyroid function in 36 dogs with leishmaniosis due to Leishmania infantum before and during treatment with allopurinol with or without meglumine antimonate.
Saridomichelakis MN; Xenoulis PG; Chatzis MK; Kasabalis D; Steiner JM; Suchodolski JS; Petanides T
Vet Parasitol; 2013 Oct; 197(1-2):22-8. PubMed ID: 23685064
[TBL] [Abstract][Full Text] [Related]
14. Total serum IgD from healthy and sick dogs with leishmaniosis.
Martínez-Orellana P; Maristany C; Baxarias M; Álvarez-Fernández A; Baldassarre A; Ordeix L; Solano-Gallego L
Parasit Vectors; 2019 Mar; 12(1):119. PubMed ID: 30909975
[TBL] [Abstract][Full Text] [Related]
15. Long term follow-up of dogs diagnosed with leishmaniosis (clinical stage II) and treated with meglumine antimoniate and allopurinol.
Torres M; Bardagí M; Roura X; Zanna G; Ravera I; Ferrer L
Vet J; 2011 Jun; 188(3):346-51. PubMed ID: 20594876
[TBL] [Abstract][Full Text] [Related]
16. Renal dialysis and long-term treatment of a dog with kidney disease associated with canine leishmaniosis.
Baneth G; Segev G; Mazaki-Tovi M; Chen H; Kuzi S
Parasit Vectors; 2018 Mar; 11(1):151. PubMed ID: 29554974
[TBL] [Abstract][Full Text] [Related]
17. Leishmania infantum exerts immunomodulation in canine Kupffer cells reverted by meglumine antimoniate.
Rodrigues A; Santos-Mateus D; Alexandre-Pires G; Valério-Bolas A; Rafael-Fernandes M; Pereira MA; Ligeiro D; de Jesus J; Alves-Azevedo R; Lopes-Ventura S; Santos M; Tomás AM; Pereira da Fonseca I; Santos-Gomes G
Comp Immunol Microbiol Infect Dis; 2017 Dec; 55():42-52. PubMed ID: 29127992
[TBL] [Abstract][Full Text] [Related]
18. Cytokine Effect of TLR3, TLR4, and TLR7 Agonists Alone or Associated with
Martínez-Orellana P; Montserrat-Sangrà S; Quirola-Amores P; González N; Solano-Gallego L
Biomed Res Int; 2018; 2018():5693736. PubMed ID: 30539014
[TBL] [Abstract][Full Text] [Related]
19. Real-time PCR assay in Leishmania-infected dogs treated with meglumine antimoniate and allopurinol.
Manna L; Reale S; Vitale F; Picillo E; Pavone LM; Gravino AE
Vet J; 2008 Aug; 177(2):279-82. PubMed ID: 17553711
[TBL] [Abstract][Full Text] [Related]
20. Relationship between serum anti-Leishmania antibody levels and acute phase proteins in dogs with canine leishmaniosis.
Cantos-Barreda A; Escribano D; Cerón JJ; Bernal LJ; Furlanello T; Tecles F; Pardo-Marín L; Martínez-Subiela S
Vet Parasitol; 2018 Aug; 260():63-68. PubMed ID: 30197018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
